Press Release

Incereb partners with SIBEN and enters the South American Market
Bringing simplified neonatal EEG monitoring to clinicians across the continent

Dublin June 19th 2017

Incereb Limited, the Dublin based medical device designer and manufacturer of neonatal EEG electrode arrays has announced a partnership with SIBEN (La Sociedad Iberoamericana de Neontalogía) that will see the introduction of a new range of neonatal sensors for brain monitoring and physiological measurement in countries across Latin and South America.

Incereb’s flagship product range neon™ is a neonatal EEG Electrode array that enables non-specialist hospital staff to attach a brain activity monitoring device in minutes to detect seizures in new born infants. Previously specialist EEG (electroencephalogram) staff were needed to install the technology that detects electrical brain impulses in children, giving vital data for early detection of oxygen deprivation and other life-threatening abnormalities.

SIBEN’s President, Sergio G. Golombek, MD, MPH, FAAP, commented “Perinatal asphyxia is a significant public health problem in Latin America. We hope that newer technologies like this will allow us to better diagnose and treat these very sick new-born infants”.

James Roche, Founder and CEO, says ‘there are approx. 10 million babies born in South America annually, the rate of admissions to the NICU stands at approx. 17.5% and we know that there is a global shortage of trained EEG technologists worldwide. The ability to quickly and easily commence neonatal EEG monitoring with minimal training is a very compelling proposition for hospitals, clinicians and the parents of patients across South America. Accessing this market also represents a major opportunity for Incereb as the market could be worth more than €19m over the next five years. This announcement builds on the appointment, in January 2017, of Brian Fawcett as Director of Distribution for Incereb in North and Latin America”.

According to globalhealthintelligence.com the fetal & neonatal care equipment market in Latin America is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.1% between 2015 and 2019, they also expect the neuro monitoring devices market in Brazil to be the fastest growing patient monitoring market in Brazil for that period.

About Incereb
In 2012, Jim Roche, Founder and CEO, identified a niche area in the Neonatal EEG Medical Device industry to which his knowledge and expertise could be applied, the company was set up and the development of a simple to use, non-invasive, single use neonatal EEG Electrode array commenced.

The company, funded by Irish investors ACT Venture Capital Limited, Delta Partners, Enterprise Ireland and the Boole HBAN Syndicate along with several private individuals, is in the process of building international distribution networks to enable a global roll out the neon™ family of devices which are CE marked and FDA approved.

Incereb is an industry partner to the Science Foundation Ireland funded INFANT Centre based at University College Cork (UCC).
See also www.incereb.com

About SIBEN
SIBEN is a Not for Profit, Public Charity Organization registered in the United States of America under the federal laws of USA.

The organization is dedicated to the improvement of life in new-borns and their families in the Latin American region through up to date continuing education, implementing high quality post graduate training with rigorous clinical and scientific standards; participating in the planning and development of teaching and clinical practice guidelines, disseminating knowledge that could help improve the quality of neonatal care at centres in all participating countries.

About Neonatal EEG
Approximately 10% of the birth population is admitted to Neonatal Intensive Care Units (NICU’s) world-wide. Up to 5/1000 live births can have seizures in the neonatal period, predominantly caused by a lack of oxygen to the brain during delivery. A much higher proportion of seizures are sub-clinical and are difficult to detect by clinical staff. Multi-Channel EEG is the gold standard for detecting seizures in the new-born. There is an international shortage of trained EEG technologists, and the EEG test can take up to an hour to set up. The neon™ EEG device enables a clinician with minimal EEG training to apply 12 EEG sensors to the infant in the NICU in a few minutes.

For further information:
Contact Simon Forsyth at sforsyth@incereb.com or +353 1 685 2245

Incereb ltd
Synergy Global
3015 Lake Drive
Citywest Business Campus
Dublin 24
(01) 6852245
www.incereb.com
info@incereb.com

Registered Office 37 Blackburne Square, Rathfarnham Gate, Rathfarnham, Dublin 14, CRO 498694 VAT no. 9789958E

Directors James Roche, Declan O’Mahoney